These findings suggest that LHX9 and PKM2 are highly expressed in GC tissue, along with the overexpression of GLUT1 and CD44, indicating their potential involvement in regulating glucose metabolism reprogramming in gastric cancer. Here, SLC2A1 is linked to gastric cancer.